|
| | Budesonide Impurity (1, 4-Androstadien-11-beta-16-alfa-diol-3, 17-dione) Basic information |
| Product Name: | Budesonide Impurity (1, 4-Androstadien-11-beta-16-alfa-diol-3, 17-dione) | | Synonyms: | Budesonide Impurity (1, 4-Androstadien-11-beta-16-alfa-diol-3, 17-dione);Budesonide Impurity (1,4-Androstadien-11-beta-16-alpha-Diol-3,17-Dione);Budesonide Impurity 16;Budesonide Impurity 2;Androsta-1,4-diene-3,17-dione, 11,16-dihydroxy-, (11β,16α)-;(11β,16α)-11,16-Dihydroxyandrosta-1,4-diene-3,17-dione;1,4-Androstadien-11-beta-16-alpha-Diol-3,17-Dione | | CAS: | 910299-74-0 | | MF: | C19H24O4 | | MW: | 316.4 | | EINECS: | | | Product Categories: | | | Mol File: | 910299-74-0.mol |  |
| | Budesonide Impurity (1, 4-Androstadien-11-beta-16-alfa-diol-3, 17-dione) Chemical Properties |
| Boiling point | 524.9±50.0 °C(Predicted) | | density | 1.29±0.1 g/cm3(Predicted) | | storage temp. | -20°C Freezer, Under inert atmosphere | | solubility | DMSO (Slightly), Methanol (Slightly) | | pka | 12.92±0.70(Predicted) | | form | Solid | | color | Off-White to Pale Beige |
| | Budesonide Impurity (1, 4-Androstadien-11-beta-16-alfa-diol-3, 17-dione) Usage And Synthesis |
| Uses | (11β,16α)-11,16-Dihydroxyandrosta-1,4-diene-3,17-dione has been identified as a budesonide tablet impurity. |
| | Budesonide Impurity (1, 4-Androstadien-11-beta-16-alfa-diol-3, 17-dione) Preparation Products And Raw materials |
|